Ptc Therapeutics, Inc. logo

PTCT

Ptc Therapeutics, Inc.

$43.18

Earnings Summary

Revenue
$186.7Mn
Net Profits
$-99.18Mn
Net Profit Margins
-53.12%

Highlights

Revenue:

Ptc Therapeutics, Inc.’s revenue fell -12.68% since last year same period to $186.7Mn in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -11.14% fall in its revenue since last 3-months.

Net Profits:

Ptc Therapeutics, Inc.’s net profit jumped 50.13% since last year same period to $-99.18Mn in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -8.3% fall in its net profits since last 3-months.

Net Profit Margins:

Ptc Therapeutics, Inc.’s net profit margin jumped 42.89% since last year same period to -53.12% in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -21.88% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ptc Therapeutics, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-1.44
EPS Estimate Current Year
-1.44

Highlights

EPS Estimate Current Quarter:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.44 - a -37.14% fall from last quarter’s estimates.

EPS Estimate Current Year:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.44.

Key Ratios

Key ratios of the Ptc Therapeutics, Inc. post its Q2 2024 earnings

Earning Per Share (EPS)
-1.27

Highlights

Earning Per Share (EPS):

Ptc Therapeutics, Inc.’s earning per share (EPS) jumped 52.26% since last year same period to -1.27 in the Q2 2024. This indicates that the Ptc Therapeutics, Inc. has generated 52.26% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-04-25
-1.24
-1.2
3.23%
2024-08-08
-1.05
-1.27
-20.95%

Discover More Earning Stocks in Health Technology Sector